Sympathetic nerve biology in essential hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 28, Issue 12, 2001, Pages 986-989

  Esler, Murray ^a,b   Rumantir, Magdalena ^a   Kaye, David ^a   Jennings, Garry ^a   Hastings, Jacqui ^a   Socratous, Flora ^a   Lambert, Gavin ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Baker Medical Research Institute   (Australia)

Author keywords

Adrenaline; Heart; Kidneys; Nerve growth factor; Pure autonomic failure

Indexed keywords

ADRENALIN; NORADRENALIN;

AGING; BIOLOGY; CATECHOLAMINE UPTAKE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; HEART; HEART NERVE; HUMAN; INNERVATION; KIDNEY; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROTRANSMISSION; NORADRENALIN RELEASE; PATHOGENESIS; PHENOTYPE; PLASMA; STRESS; SYMPATHETIC NERVE;

AGING; ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; HYPERTENSION; KINETICS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, INBRED SHR; SYMPATHETIC NERVOUS SYSTEM; SYMPORTERS;

EID: 0035681029     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2001.03566.x     Document Type: Conference Paper

References (21)

1. Overflow of catecholamine neurotransmitters to the circulation: Source, fate and functions
2. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure
3. Single-unit sympathetic discharge. Quantitative assessment in human hypertensive disease
4. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: An influence upon neuroeffector mechanisms
5. Reduced myocardial nerve growth factor expression in human and experimental heart failure
6. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure
7. Sympathetic cardioneuropathy in dysautonomias
8. The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves
9. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension
10. Epinephrine and the genesis of hypertension
11. Activation of prejuctional β-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter
12. The 'adrenaline hypothesis' of hypertension revisited: Evidence for adrenaline release from the heart of patients with essential hypertension
13. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks
14. Sympathetic activity in experimental and human hypertension
15. Norepinephrine kinetics in essentail hypertension. Defective neuronal uptake of norepinephrine in some patients
16. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension
17. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency
18. Phenotypic evidence of faulty neuronal noradrenaline reuptake in essential hypertension
19. Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders
20. Topical review. Human ageing and the sympathoadrenal system